Introduction
The simian immunodeficiency virus (SIV) macaque model resembles infection of individuals with human immunodeficiency virus (HIV) in terms of disease progression and acquired immunodeficiency syndrome (AIDS). In addition, SIV-infected macaques can develop motor and cognitive impairments as occurs in human neuro-AIDS (Murray et al., 1992; Williams et al., 2008), and Weed et al. (2004) note that behavioral impairments produced by SIV and HIV on homologous primate test batteries, such as the CANTAB, are quite similar. SIV-induced encephalitis is characterized by general gliosis, nodule and giant cell formation, inflammatory cell infiltrates, myelin pallor, and vessel leakage (Budka, 1986; Weihe et al., 1993; Lane et al., 1996; Luabeya et al., 2000) . Loss of synapses, dendrites, and neurons also occurs in SIV disease (Li et al., 1999; Luthert et al., 1995; Bissel et al., 2002) . Neurodegenerative damage could be caused by virus-derived as well as host-derived neurotoxic products (Li et al., 1999) and is thought to be related to SIV replication and the number of inflammatory cells infiltrating and becoming activated in the central nervous system (Glass et al., 1995; Bissel et al., 2002) .
Cyclooxygenases (COX) catalyze the rate-limiting step in the conversion of arachidonic acid to prostaglandins and thromboxanes, lipid mediators involved in several physiological and pathological processes in the brain (Smith et al., 2000; Bosetti, 2007) . Inflammation, associated with an increased expression of COX and elevated levels of prostaglandins, has been implicated in a variety of acute and chronic neurologic and neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and HIV infection (Griffin et al., 1994; Maihöfner et al., 2003; Teismann et al., 2003; Hoozemans et al., 2008) . COX-derived prostaglandins promote migration of monocyte-derived cells (Legler et al., 2006; Tajima et al., 2008) as well as breakdown of the bloodbrain barrier (BBB) (Schmidley et al., 1992) . The two distinct COX isoforms, COX1 and COX2, share 60% homology in their amino acid sequence and have comparable kinetics (Smith et al., 2000) . However, the two isoforms differ in regulatory mechanisms, preferential coupling to upstream and downstream enzymes (Murakami and Kudo, 2004) , and in modulating inflammatory response in the brain (Aid et al., 2008; Choi et al., 2008) .
Data on the roles of COX1 and COX2 are controversial and complicated by the use of different animal models. COX1 has been classically considered as the isoform primarily responsible for Neurobiology of Disease 42 (2011) 108-115 
